• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,664.21 -999.79
( -1.29%)
Global Indices
Nasdaq
49,249.13 -82.20
(-0.17%)
Dow Jones
7,185.72 56.32
(0.79%)
Hang Seng
59,744.07 603.84
(1.02%)
Nikkei 225
10,387.94 -69.07
(-0.66%)
Forex
USD-INR
94.05 0.29
(0.31%)
EUR-INR
109.99 0.01
(0.01%)
GBP-INR
126.84 0.17
(0.14%)
JPY-INR
0.59 0.00
(0.16%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
205.5515954
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
37.65
743.57
EPS(TTM)
Face Value()
Div & Yield %
16.76
10
0.24
 

Urja Global Ltd - Board Meeting Intimation for To Consider And Approve The Un-Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Half-Year Ended On 30Th September 2025.
Oct 10,2025
Urja Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/10/2025 inter alia to consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Half-year ended on 30th September 2025.